ClinicalTrials.Veeva

Menu

AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS (AI-ECG TIMI)

P

Powerful Medical

Status

Invitation-only

Conditions

NSTEMI - Non-ST Segment Elevation MI
Coronary Syndrome
Acute Coronary Syndrome
NSTEMI
STEMI
Coronary Occlusion

Study type

Observational

Funder types

Other

Identifiers

NCT06528821
AI-ECG-TIMI_v1

Details and patient eligibility

About

AI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting coronary blood flow alteration. The aim of the study is to identify electrocardiographic findings detected by an automated artificial intelligence (AI) model that can predict coronary blood flow alteration as assessed by the TIMI grade flow at the very moment of the invasive coronary angiography in patients with acute coronary syndromes.

Enrollment

800 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute coronary syndromes undergoing invasive coronary angiography as clinically indicated.
  • Availability of a standard 12-lead ECG performed at invasive coronary angiogram before percutaneous coronary intervention (maximum within 15 min before vascular access).
  • Age ≥18 years.

Exclusion criteria

  • Individuals presenting for a non-emergent (elective) cardiac catheterization.
  • Individuals presenting with chronic coronary syndrome (CCS) or stable angina symptoms.
  • Individuals without symptoms suspicious for acute coronary syndromes.
  • Individuals with contraindications for cardiac catheterization.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems